{
  "pmcid": "11637585",
  "sha256": "8c3973596ec9d41c16d71b02db2ae95e090529000ec22bd9f35e2b52972aa459",
  "timestamp_utc": "2025-11-09T23:18:25.892175+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.910483602001111,
    "reading_ease": 31.467808041504583,
    "word_count": 257
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Effect of Reverse Bevel Nasotracheal Intubation on Epistaxis"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised controlled trial was conducted at Asan Medical Center, Seoul, Korea, from November 2021 to September 2023."
      },
      "Participants": {
        "score": 2,
        "evidence": "Seventy-four patients undergoing right-sided maxillofacial surgery requiring left nasotracheal intubation"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly allocated to either the control group (conventional tube direction) or the reverse group (180˚ reverse bevel direction)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated the effect of a 180˚ reverse bevel and tip direction of the nasotracheal tube on the incidence of epistaxis during left nostril intubation."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of epistaxis, assessed via videolaryngoscopy."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using web-based software, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Seventy-four patients undergoing right-sided maxillofacial surgery requiring left nasotracheal intubation"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "9/37 [24.3%]) compared to the control group (20/37 [54.1%]"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "relative risk: 0.45, 95% CI [0.24, 0.85], absolute risk reduction: 29.8%, number needed to treat: 3"
      },
      "Harms": {
        "score": 1,
        "evidence": "No nasotracheal tube-related complications were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: KCT0006672."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}